Trial Profile
Study of edoxaban in the prevention of stroke and embolism systemic
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation; Deep vein thrombosis; Embolism; Stroke
- Focus Therapeutic Use
- 25 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association